Filtered By:
Therapy: Immunotherapy
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 6127 results found since Jan 2013.
From the Pages of AllergyWatch
For this edition of From the Pages of AllergyWatch, I've chosen articles from recent issues of AllergyWatch. The first article, with comments from Dr. Chipps, reports data showing a reduction in exacerbations and infections in asthma patients receiving allergen immunotherapy. The next article, with comments from Dr. Lee, also investigates allergen immunotherapy and improvements in atopic dermatitis. The third article, with comments from Dr. Joshi, is an analysis of the types of infant formula used in the US and the various carbohydrate sources.
Source: Annals of Allergy, Asthma and Immunology - July 18, 2023 Category: Allergy & Immunology Authors: Stanley Fineman, Gerald B. Lee, Bradley E. Chipps, Shyam R. Joshi Tags: Special Series Source Type: research
Fire Ant Immunotherapy with InteRvals Extended to 12-weekS: The FIRES Study
CONCLUSION: This prospective longitudinal cohort study shows that in adults >18 years old who have received at least 3 months of maintenance dose IFA WBE immunotherapy with proven efficacy, extension to a 12-week EMI is a safe effective treatment option. Benefits of extended maintenance intervals include reduced number of injections, clinic visits, and lapses in maintenance immunotherapy.PMID:37454809 | DOI:10.1016/j.anai.2023.06.027
Source: Annals of Allergy, Asthma and Immunology - July 16, 2023 Category: Allergy & Immunology Authors: Brittanie Neaves Karla Adams Derek Smith Rebecca Schapira Thad OCampo Kevin White Kirk Waibel Michael Tankersley Shayne Stokes Source Type: research
Occupational Rhinitis: An Update
Discussion includes the impact of social trends on workers and the wider consequences of occupational rhinitis including decreased work productivity, absenteeism, and socioeconomic burden.SummaryOccupational rhinitis remains a challenging disease entity due to the numerous potential causative factors, reduced recognition, morbidity in asthma, and therapeutic limitations. Additional research is needed to better identify disease predictors and develop effective management strategies.
Source: Current Allergy and Asthma Reports - July 15, 2023 Category: Allergy & Immunology Source Type: research
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy
Allergen immunotherapy (AIT) is a well-established disease-modifying therapy for allergic rhinitis, yet the fundamental mechanisms underlying its clinical effect remain inadequately understood.
Source: Journal of Allergy and Clinical Immunology - July 14, 2023 Category: Allergy & Immunology Authors: Matthew C. Altman, R Max Segnitz, David Larson, Naresh Doni Jayavelu, Malisa Smith, Sana Patel, Guy W. Scadding, Tielin Qin, Srinath Sanda, Esther Steveling, Aarif O. Eifan, Martin Penagos, Mikila R. Jacobson, Rebecca V. Parkin, Mohamed H. Shamji, Alkis T Source Type: research
Fire Ant Immunotherapy with InteRvals Extended to 12-weekS: The FIRES Study
: There are no studies describing 12-week extended maintenance interval immunotherapy efficacy in preventing anaphylaxis to imported fire ant (IFA) stings.
Source: Annals of Allergy, Asthma and Immunology - July 14, 2023 Category: Allergy & Immunology Authors: Brittanie Neaves, Karla Adams, Derek Smith, Rebecca Schapira, Thad OCampo, Kevin White, Kirk Waibel, Michael Tankersley, Shayne Stokes Tags: Original Article Source Type: research
Fire ant Immunotherapy with inteRvals Extended to 12 weekS
There are no studies describing 12-week extended maintenance interval (EMI) immunotherapy (IT) efficacy in preventing anaphylaxis to imported fire ant (IFA) stings.
Source: Annals of Allergy, Asthma and Immunology - July 14, 2023 Category: Allergy & Immunology Authors: Brittanie Neaves, Karla Adams, Derek Smith, Rebecca Schapira, Thad Ocampo, Kevin White, Kirk Waibel, Michael Tankersley, Shayne Stokes Source Type: research
Immunotherapy Stewardship Could Save Tens of Millions a Year Immunotherapy Stewardship Could Save Tens of Millions a Year
Weight-based dosing, dose rounding, and pharmacy-level vial sharing for immune checkpoint inhibitors could save the Veterans Health Administration more than $70 million annually.Medscape Medical News
Source: Medscape Allergy Headlines - July 13, 2023 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Update on oral and epicutaneous immunotherapy for children with food allergy
ConclusionThe implementation of recent treatment protocols has significantly improved the safety of OIT. Therefore, its continuation using safety protocols can be considered in the selection of the optimal OIT for individual patients, as provision of safe and effective treatment is crucial for the success of OIT.
Source: Allergo Journal International - July 11, 2023 Category: Allergy & Immunology Source Type: research
Infant Egg Allergy Unaffected by Mom's Early Postnatal Diet
(MedPage Today) -- Infants were no less likely to develop egg allergy if their mother ate eggs in the days after delivery as a means of low-dose oral immunotherapy via breast milk, a randomized clinical trial showed.
At 12 months of age, egg allergy...
Source: MedPage Today Allergy - July 10, 2023 Category: Allergy & Immunology Source Type: news
Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in adults undergoing immunotherapy in a tropical country: Is ISAAC-III questionnaire useful in adult populations?
CONCLUSION: The main factor associated with AR was regular acetaminophen use, while that associated with CARAS was cesarean delivery. The ISAAC-III questionnaire can be a useful low-cost tool to assess the factors associated with allergic diseases in adults in tropical countries.PMID:37422783 | DOI:10.15586/aei.v51i4.833
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Augusto Pe ñaranda Luc ía C Pérez-Herrera Manuela Gantiva Sergio Moreno-L ópez Julian Manrique Daniel Pe ñaranda Elizabeth Garc ía Source Type: research
